E series prostaglandins alter the proliferative, apoptotic and migratory properties of T98G human glioma cells in vitro

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Gomes, Renata N ^a   Colquhoun, Alison ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apoptosis; Glioma; Ibuprofen; Migration; Prostaglandin

Indexed keywords

CASPASE 3; CASPASE 9; IBUPROFEN; PROSTAGLANDIN E1; PROSTAGLANDIN E2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INDEX; PROSTAGLANDIN METABOLISM;

ALPROSTADIL; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; GLIOMA; HUMANS; IBUPROFEN;

EID: 84870666342     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-171     Document Type: Article

References (34)

1. Epidemiology of brain tumors. Ohgaki H, Methods Mol Biol 2009 472 42
2. The 2007 WHO Classification of Tumours of the Central Nervous System. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P, Acta Neuropathol 2007 114 2 97 109 10.1007/s00401-007-0243-4 17618441 (Pubitemid 47103521)
3. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Ulrich CM, Bigler J, Potter JD, Nat Rev Cancer 2006 6 2 130 140 10.1038/nrc1801 16491072 (Pubitemid 43361545)
4. Non-steroidal anti-inflammatory drug use and colorectal polyps in the prostate, lung, colorectal, and ovarian cancer screening trial. Johnson CC, Hayes RB, Schoen RE, Gunter MJ, Huang WY, Am J Gastroenterol 2010 105 12 2646 2655 10.1038/ajg.2010.349 20808298
5. Nonsteroidal anti-inflammatory drugs and cancer prevention. Baron JA, Sandler RS, Annu Rev Med 2000 51 511 523 10.1146/annurev.med.51.1.511 10774479 (Pubitemid 30216052)
6. Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. de Groot DJ, de Vries EG, Groen HJ, de Jong S, Crit Rev Oncol Hematol 2007 61 1 52 69 10.1016/j.critrevonc.2006.07.001 16945549 (Pubitemid 44880148)
7. Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer. Tseng WW, Deganutti A, Chen MN, Saxton RE, Liu CD, J Gastrointest Surg 2002 6 6 838 843 10.1016/S1091-255X(02)00061-6 12504222 (Pubitemid 40433470)
8. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K, Cancer Res 2000 60 5 1306 1311 10728691 (Pubitemid 30151999)
9. Cyclooxygenase in biology and disease. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE, FASEB J 1998 12 1063 1073 9737710 (Pubitemid 28418937)
10. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Simmons DL, Botting RM, Hla T, Pharmacol Rev 2004 56 3 387 437 10.1124/pr.56.3.3 15317910 (Pubitemid 39096597)
11. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF, Cancer Res 2001 61 11 4375 4381 11389063 (Pubitemid 32685762)
12. Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme. Lalier L, Cartron PF, Pedelaborde F, Olivier C, Loussouarn D, Martin SA, Meflah K, Menanteau J, Vallette FM, Oncogene 2007 26 34 4999 5009 10.1038/sj.onc.1210303 17369862 (Pubitemid 47172649)
13. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with IBP, a nonselective cyclooxygenase inhibitor. Li W, Xu RJ, Lin ZY, Zhuo GC, Zhang HH, Med Oncol 2009 26 2 170 177 10.1007/s12032-008-9104-9 18988002
14. NS-398, IBP, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells. John-Aryankalayil M, Palayoor ST, Cerna D, Falduto MT, Magnuson SR, Coleman CN, Mol Cancer Ther 2009 8 1 261 273 10.1158/1535-7163.MCT-08-0928 19139136
15. Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-IBP treatment. Janssen A, Maier TJ, Schiffmann S, Coste O, Seegel M, Geisslinger G, Grösch S, Eur J Pharmacol 2006 540 1-3 24 33 16730702 (Pubitemid 43884823)
16. Diruthenium (II, III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: synthesis, characterization and their effects on tumour cell proliferation. Ribeiro G, Benadiba M, Colquhoun A, Silva DO, Polyhedron 2008 27 1131 1137 10.1016/j.poly.2007.12.011
17. Inhibition of C6 rat glioma proliferation by [Ru2Cl(Ibp)4] depends on changes in p21, p27, Bax/Bcl2 ratio and mitochondrial membrane potential. Benadiba M, Dos Santos RR, Silva Dde O, Colquhoun A, J Inorg Biochem 2010 104 9 928 935 10.1016/j.jinorgbio.2010.04.011 20605638
18. PGE1 and PGE2 modify platelet function through different prostanoid receptors. Iyú D, Jüttner M, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S, Prostaglandins Other Lipid Mediat 2011 94 1-2 9 16 21095237
19. Effects of saturated and polyunsaturated fatty acids on human tumor-cell proliferation. Colquhoun A, Curi R, Gen Pharmacol 1998 30 2 191 194 10.1016/S0306-3623(97)00110-9 9502173 (Pubitemid 28026720)
20. Protective role of glucose-6-phosphate dehydrogenase activity in the metabolic response of C6 rat glioma cells to polyunsaturated fatty acid exposure. Ramos KL, Colquhoun A, Glia 2003 43 2 149 166 10.1002/glia.10246 12838507 (Pubitemid 36897276)
21. Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression. Miyake JA, Benadiba M, Colquhoun A, Lipids Health Dis 2009 8 8 10.1186/1476-511X-8-8 19292920
22. Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Kardosh A, Blumenthal M, Wang WJ, Chen TC, Schönthal AH, Cancer Biol Ther 2004 3 1 55 62 10.4161/cbt.3.1.571 14726653 (Pubitemid 41342419)
23. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. Sheng H, Shao J, Washington MK, DuBois RN, J Biol Chem 2001 276 21 18075 18081 10.1074/jbc.M009689200 11278548
24. Eicosanoids and cancer. Wang D, Dubois RN, Nat Rev Cancer 2010 10 3 181 193 10.1038/nrc2809 20168319
25. Prostaglandins in cancer cell adhesion, migration, and invasion. Menter DG, Dubois RN, Int J Cell Biol 2012 2012 723419 22505934
26. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation. Chiu WT, Shen SC, Chow JM, Lin CW, Shia LT, Chen YC, Neurobiol Dis 2010 37 1 118 129 10.1016/j.nbd.2009.09.015 19804834
27. Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E(2)-dependent activation of type II protein kinase A. Payner T, Leaver HA, Knapp B, Whittle IR, Trifan OC, Miller S, Rizzo MT, Mol Cancer Ther 2006 5 7 1817 1826 10.1158/1535-7163.MCT-05-0548 16891468 (Pubitemid 44323250)
28. Nanoprodrugs of NSAIDs Inhibit the Growth of U87-MG Glioma Cells. Lee BS, Yuan, Xu O, Ko MK, Nalla AK, Frankiel I, Shear T, Black KL, Yu JS, J Nanomater 2010 372 1-2 112 124
29. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases. Lee J, Banu SK, Subbarao T, Starzinski-Powitz A, Arosh JA, Mol Cell Endocrinol 2010 30 3 377 386
30. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells. Bai XM, Zhang W, Liu NB, Jiang H, Lou KX, Peng T, Ma J, Zhang L, Zhang H, Leng J, Oncol Rep 2009 21 1 129 136 19082453
31. Receptor and enzyme expression for prostanoid metabolism in colorectal cancer related to tumor tissue PGE2. Gustafsson A, Andersson M, Lagerstedt K, Lönnroth C, Nordgren S, Lundholm K, Int J Oncol 2010 36 2 469 478 20043083
32. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study. Bernardi A, Frozza RL, Jäger E, Figueiró F, Bavaresco L, Salbego C, Pohlmann AR, Guterres SS, Battastini AM, Eur J Pharmacol 2008 586 1-3 24 34 18371953
33. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Bernardi A, Braganhol E, Jäger E, Figueiró F, Edelweiss MI, Pohlmann AR, Guterres SS, Battastini AM, Cancer Lett 2009 281 1 53 63 10.1016/j.canlet.2009.02.018 19286307
34. Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Kim SR, Bae MK, Kim JY, Wee HJ, Yoo MA, Bae SK, Carcinogenesis 2009 30 3 377 386 10.1093/carcin/bgp014 19136477